Cellebrite DI Ltd.
CLBT
$14.44
-$0.09-0.62%
NASDAQ
| 12/31/2025 | 06/30/2025 | 12/31/2024 | 09/30/2024 | ||
|---|---|---|---|---|---|
| Revenue | -- | -- | 401.20M | 385.17M | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | -- | 401.20M | 385.17M | |
| Cost of Revenue | -- | -- | 62.60M | 59.89M | |
| Gross Profit | -- | -- | 338.61M | 325.28M | |
| SG&A Expenses | -- | -- | 183.29M | 174.54M | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | -- | -- | 344.30M | 328.99M | |
| Operating Income | -- | -- | 56.90M | 56.18M | |
| Income Before Tax | -- | -- | -275.98M | -308.23M | |
| Income Tax Expenses | -- | -- | 7.02M | 8.70M | |
| Earnings from Continuing Operations | -- | -- | -283.01 | -316.92 | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -- | -- | -283.01M | -316.92M | |
| EBIT | -- | -- | 56.90M | 56.18M | |
| EBITDA | -- | -- | 67.51M | 66.67M | |
| EPS Basic | -- | -- | -1.39 | -1.55 | |
| Normalized Basic EPS | -- | -- | -0.02 | -0.11 | |
| EPS Diluted | -- | -- | -1.40 | -1.56 | |
| Normalized Diluted EPS | -- | -- | -0.02 | -0.11 | |
| Average Basic Shares Outstanding | -- | -- | 837.73M | 798.92M | |
| Average Diluted Shares Outstanding | -- | -- | 851.83M | 798.92M | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |